Checkrein deformity represents a dynamic claw toe deformity. Surgical intervention is the treatment of choice and many methods have been proposed. The purpose of this study is to evaluate the outcomes and complications of percutaneous segmental tenotomy of the toe flexor tendons.

Percutaneous Tenotomy of the Toe Flexor Tendon is a Simple and Efficient Method in Treating Checkrein Deformity

Further study details as provided by National Taiwan University Hospital:

Estimated Enrollment:

14

Study Start Date:

March 2012

Estimated Study Completion Date:

March 2013

Estimated Primary Completion Date:

January 2013 (Final data collection date for primary outcome measure)

Detailed Description:

The investigators reviewed fourteen patients with checkrein deformity who underwent surgery in our hospital between 1993 and 2010. Five patients received FHL and flexor digitorum longus (FDL) tenolysis at the musculotendinous junction; among them, two also underwent Z-plasty lengthening of the FHL tendon. Nine patients underwent percutaneous segmental toe flexor tenotomy. The Hallux Metatarsophalangeal- Interphalangeal Scale (Hallux MTP-IP scale) and Foot and Ankle Outcome Score (FAOS), English version LK1.0 self-explanatory questionnaire were used to evaluate the functional outcomes.

Eligibility

Ages Eligible for Study:

18 Years to 73 Years

Genders Eligible for Study:

Both

Accepts Healthy Volunteers:

No

Sampling Method:

Probability Sample

Study Population

There were fourteen patients with checkrein deformity who underwent surgery in our hospital between 1993 and 2010.

Criteria

Inclusion Criteria:

Patients with checkrein deformity who underwent surgery in our hospital between 1993 and 2010.

Exclusion Criteria:

Patients who had static or rigid claw toe deformity

Patients who had claw toe deformity secondary to neuromuscular disease

Contacts and Locations

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01725893